|
|
Post by cretin11 on Sept 13, 2023 21:42:32 GMT -5
Peppy, I think MC and I are saying the same thing. He had his usual positive spin and I had my usual realistic spin. Your “realistic spin” is an oxymoron of course, as it’s not spin if your intention is to be realistic. Regardless, your realistic take is appreciated. |
|
|
|
Post by cretin11 on Sept 13, 2023 21:50:00 GMT -5
Definitely looking forward to the MS coverage and curious what the price target will be on the rec. GS coverage would be tasty icing on the cupcake. How do you know there will be Morgan Stanley coverage of MNKD? Is it really a slam-dunk? I continue to be skeptical but maybe you can persuade me. A slam dunk? Maybe a layup is more accurate, but that’s semantics. I will refer you to read tarheelblue’s FY25 forecast. None of that information is secret. So assuming MC did a competent and credible job of conveying MNKD’s situation (in other words, convert the layup/slam dunk), what possible reason could there be for MS not issuing a buy rec? They are in the business of doing exactly that, if they view a stock as indeed a buy. |
|
|
|
Post by prcgorman2 on Sept 13, 2023 22:59:53 GMT -5
How do you know there will be Morgan Stanley coverage of MNKD? Is it really a slam-dunk? I continue to be skeptical but maybe you can persuade me. A slam dunk? Maybe a layup is more accurate, but that’s semantics. I will refer you to read tarheelblue’s FY25 forecast. None of that information is secret. So assuming MC did a competent and credible job of conveying MNKD’s situation (in other words, convert the layup/slam dunk), what possible reason could there be for MS not issuing a buy rec? They are in the business of doing exactly that, if they view a stock as indeed a buy. Speaking of a layup, you’re welcome for the way I cleared the path for you to make the argument which implies only an inept CEO could possibly fail to have presented MNKD sufficiently for a Morgan Stanley to overlook the opportunity to buy-in on MNKD and initiate coverage and a share price target. I don’t share your opinion but I appreciate you sharing it. |
|
Dartman
Newbie
Posts: 24 
Sentiment: Way Too Long
|
Post by Dartman on Sept 13, 2023 23:54:24 GMT -5
How do you know there will be Morgan Stanley coverage of MNKD? Is it really a slam-dunk? I continue to be skeptical but maybe you can persuade me. There's no guarantee that Morgan Stanley will initiate coverage but due to the fact that MNKD was INVITED to their conference and the stock price is BELOW $5.00 really sends a strong message that they are very interested in the company. Someone on Stocktwits made the observation that the MS Analyst was well versed on MNKD's history. That tells me they are very interested. When I first invested in MNKD, way too many years ago, MS was my broker and provided the recommendation to invest. They conveyed a compelling story that sold me. I now know way too much about diabetes for someone without diabetes. And I'm still invested. Probably the same analyst... |
|
|
|
Post by cretin11 on Sept 14, 2023 2:14:23 GMT -5
A slam dunk? Maybe a layup is more accurate, but that’s semantics. I will refer you to read tarheelblue’s FY25 forecast. None of that information is secret. So assuming MC did a competent and credible job of conveying MNKD’s situation (in other words, convert the layup/slam dunk), what possible reason could there be for MS not issuing a buy rec? They are in the business of doing exactly that, if they view a stock as indeed a buy. Speaking of a layup, you’re welcome for the way I cleared the path for you to make the argument which implies only an inept CEO could possibly fail to have presented MNKD sufficiently for a Morgan Stanley to overlook the opportunity to buy-in on MNKD and initiate coverage and a share price target. I don’t share your opinion but I appreciate you sharing it. Interesting take, and you are providing a possible reason for MS not to initiate coverage. Despite that logic, my prediction is they will issue the buy rec as expected and I’m curious what the price target will be. |
|
|
|
Post by ronw77077 on Sept 14, 2023 10:11:17 GMT -5
I received a belated invitation to the Wainwright 9/11 - 9/13 25th Annual Global Investment Conference. It appears that there were 597 companies participating with on demand sessions company presentations(some could be attended). Of the total there were 77 Fireside Chats such as the one MNKD participated in. If there is something to be gleaned from this I don't know what it is, but thought I would offer up the information.
|
|
|
|
Post by markado on Sept 14, 2023 15:55:38 GMT -5
No telling if or when in the near term MS may initiate coverage and issue a buy recommendation with a price target, but based on a Google search of "Morgan Stanley initiates coverage", the first five results with time stamps had 3 after 5p Eastern and two before 8a Eastern. Obviously, not likely to occur during market hours so as to not unduly influence trading. So, I guess we shall see...
|
|
|
|
Post by anderson on Sept 14, 2023 21:45:51 GMT -5
At 24:04 Mike mentioned Cipla and inhaled 2. "The results are in and they are intending to file for approval"
|
|
|
|
Post by markado on Sept 16, 2023 9:42:15 GMT -5
No telling if or when in the near term MS may initiate coverage and issue a buy recommendation with a price target, but based on a Google search of "Morgan Stanley initiates coverage", the first five results with time stamps had 3 after 5p Eastern and two before 8a Eastern. Obviously, not likely to occur during market hours so as to not unduly influence trading. So, I guess we shall see... Further on this topic, all of the initiate coverage announcements I could find on Google were issued on Mon, Tue or Wed, with Tue having the highest representation. So, provided the timing of the presentation, and these combined search results, maybe be on the lookout for word from MS, by 1159p, We, this week? As a long-time long, I certainly hope so. |
|
|
|
Post by tarheelblue004 on Sept 16, 2023 10:16:56 GMT -5
markado all good but the underlying assumption is that companies invited to MS conferences (or the healthcare conference specifically) are more likely to have coverage initiated by MS post-conference. Do you have any observations showing that to be true?
|
|
|
|
Post by prcgorman2 on Sept 16, 2023 14:12:29 GMT -5
Since they kindly waited for me to add, I hope they now feel compelled to re-initiate coverage and a share price target (as LONG as the target is north of where the SP is now). My gut says unlikely, but it’s one of those times I’d be delighted to be wrong.
|
|
|
|
Post by markado on Sept 16, 2023 14:16:19 GMT -5
markado all good but the underlying assumption is that companies invited to MS conferences (or the healthcare conference specifically) are more likely to have coverage initiated by MS post-conference. Do you have any observations showing that to be true? I think it is as reasonable assumption as any, provided the MS analysts' detailed interest and understanding of MNKD's business, and the invitation to present in the first place. But, no guarantees of course. After all this is MNKD. I guess we'll find out. |
|
|
|
Post by agedhippie on Sept 16, 2023 17:59:32 GMT -5
Do people understand exactly how large this conference is? There are seven tracks, three days, 200+ companies. You apply to present and then they stack rank and slot you. In Mannkind's case got the 8:10am slot on the lower level (it could have been worse, there is a 7:30am slot).
The time slot is a bit of a killer, but being out of the mainstream (UTHR got a midday slot in one of the 2nd floor ballrooms) is not necessarily bad. There are investors there fishing for up and coming companies and those less favored rooms are where they go. This is about exposure and that works in this case as anyone who was there really wanted to be there.
Will Morgan Stanley initiate coverage? Probably at some point, coverage is not as big deal as people think when you are Mannkind's size. Most of the companies in Mannkind's track are covered by Morgan Stanley and their share price doesn't really react to downgrades or upgrades. Professional investors care far more about who the analyst is than who the financial is - a good analyst at Wainwright has more influence than a poor analyst at Morgan Stanley.
|
|
|
|
Post by markado on Sept 21, 2023 17:54:29 GMT -5
No telling if or when in the near term MS may initiate coverage and issue a buy recommendation with a price target, but based on a Google search of "Morgan Stanley initiates coverage", the first five results with time stamps had 3 after 5p Eastern and two before 8a Eastern. Obviously, not likely to occur during market hours so as to not unduly influence trading. So, I guess we shall see... Like too many other missed opportunities, timely announcement of initiated coverage by MS does not appear in the cards for MNKD. Just one more chit on the scales of injustice for this holding. We remain Castagnant. |
|
|
|
Post by cretin11 on Sept 21, 2023 23:18:42 GMT -5
No telling if or when in the near term MS may initiate coverage and issue a buy recommendation with a price target, but based on a Google search of "Morgan Stanley initiates coverage", the first five results with time stamps had 3 after 5p Eastern and two before 8a Eastern. Obviously, not likely to occur during market hours so as to not unduly influence trading. So, I guess we shall see... Like too many other missed opportunities, timely announcement of initiated coverage by MS does not appear in the cards for MNKD. Just one more chit on the scales of injustice for this holding. We remain Castagnant. Perhaps the buy rec will happen next week. Share price has only gone down since the presentation, so it would give MS more room to set a robust price target. If not, then I agree yet another missed opportunity. Not sure about scales of injustice. MS wants to look good by making accurate recs, so if they weren’t persuaded by the presentation then perhaps they know better than we do. They are certainly more objective than everyone here on PB. |
|
